Synthesis, Antioxidant and In-Silico Studies of Potent Urease Inhibitors: N-(4-{[(4-Methoxyphenethyl)-(substituted)amino]sulfonyl}phenyl)acetamides

Abstract

In this study, a new series of sulfonamides derivatives was synthesized and their inhibitory effects on DPPH and jack bean urease were evaluated. The in silico studies were also applied to ascertain the interactions of these molecules with active site of the enzyme. Synthesis was initiated by the nucleophilic substitution reaction of 2-(4-methoxyphenyl)-1-ethanamine (1) with 4-(acetylamino)benzenesulfonyl chloride (2) in aqueous sodium carbonate at pH 9. Precipitates collected were washed and dried to obtain the parent molecule, N-(4-{[(4-methoxyphenethyl)amino]sulfonyl}phenyl)acetamide (3). Then, this parent was reacted with different alkyl/aralkyl halides, (4a-m), using dimethylformamide (DMF) as solvent and LiH as an activator to produce a series of new N-(4-{[(4-methoxyphenethyl)-(substituted)amino]sulfonyl}phenyl)acetamides (5a-m). All the synthesized compounds were characterized by IR, EI-MS, ¹H-NMR, ¹³C-NMR and CHN analysis data. All of the synthesized compounds showed higher urease inhibitory activity than the standard thiourea. The compound 5 f exhibited very excellent enzyme inhibitory activity with IC₅₀ value of 0.0171±0.0070 µM relative to standard thiourea having IC₅₀ value of 4.7455±0.0546 µM. Molecular docking studies suggested that ligands have good binding energy values and bind within the active region of taget protein. Chemo-informatics properties were evaluated by computational approaches and it was found that synthesized compounds mostly obeyed the Lipinski’ rule.

Key words

Sulfonamides - acetamides - alkyl/aralkyl halides - spectral analysis - antioxidant - Urease inhibition - Molecular docking

• References

• 1 You Z-L, Ni L-L, Shi D-H. et al. Synthesis, structures, and urease inhibitory activities of three copper(II) and zinc(II) complexes with 2-{[2-(2-hydroxyethylamino)ethyl-imino]methyl}-4-nitrophenol. Eur J Med Chem 2010; 45: 3196-3199
• 2 Lin YT, Kwon YI, Labbe RG. et al. Inhibition of Helicobacter pylori and associated urease by Oregano and Cranberry phytochemical synergies. App Env Microbiol 2005; 71: 8558-8564
• 3 Modolo LV, de Souza AX, Horta LP. et al. An overview on the potential of natural products as ureases inhibitors: A review. J Adv Res 2015; 6: 35-44
• 4 Maroney MJ, Ciurli S. Nonredox Nickel Enzymes. Chem Rev 2014; 114: 4206-4228
• 5 Sujoy B, Aparna A. Potential clinical significance of urease enzyme. Eur Sci J 2013; 9: 94-102
• 6 Boer JL, Mulrooney SB, Hausinger RP. Nickel-dependent metalloenzymes. Arch Biochem Biophy 2014; 544 Supplement C 142-152
• 7 Algood HMS, Cover TL. Helicobacter pylori persistence: An overview of interactions between H. pylori and Hhost immune defenses. Clin Microbiol Rev 2006; 19: 597-613
• 8 Shaabani A, Soleimani E, Rezayan AH. A novel approach for the synthesis of alkyl and aryl sulfonamides. Tet. Lett 2007; 48: 2185-2188
• 9 Dauban P, Dodd RH. Synthesis of Cyclic Sulfonamides via Intramolecular Copper-Catalyzed Reaction of Unsaturated Iminoiodinanes. Org Lett 2000; 2: 2327-2329
• 10 Wilson CO, Gisvold O, Block JH. Textbook of Organic Medicinal and Pharmaceutical Chemistry. Lippincott Williams and Wilkins; Philadelphia, USA: 2004. 11th edition
• 11 Levin JI, Chen JM, Du MT. et al. Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 2: SAR of the acetylenic P1’ group. Bioorg Med Chem. Lett 2002; 12: 199-202
• 12 Hu B, Ellingboe J, Han S. et al. Novel (4-piperidin-1-yl)-phenyl sulfonamides as potent and selective human beta (3) agonists. Bioorg Med Chem 2001; 9: 2045-2059
• 13 Stokes SS, Albert R, Buurman EdT. et al. Inhibitors of the acetyltransferase domain of N-acetylglucosamine-1-phosphateuridylyltransferase/glucosamine-1-phosphate-acety ltransferase (GlmU). Part 2: Optimization of physical properties leading to antibacterial aryl sulfonamidesBioorg. Med Chem Lett 2012; 22: 7019-7023
• 14 Chibale K, Haupt H, Kendrick H. et al. Bioorg. Med Chem Lett 2001; 11: 2655-2657
• 15 Rahavi EI, Camoutsis C, Zoumpoulakis P. et al. Sulfonamide-1,2,4-triazole derivatives as antifungal and antibacterial agents: Synthesis, biological evaluation, lipophilicity, and conformational studies. Bioorg Med Chem 2008; 16: 1150-1161
• 16 Kennedy JF, Thorley M. Pharmaceutical Substances. 1999 3rd edition. Kleeman A, Engel J, Kutscher B, Reichert D. Thieme; Stuttgart: 1999
• 17 Serradeil-Le GC. Cardiovasc. Drug Rev 2001; 19: 201-214
• 18 Natarajan A, Guo Y, Harbinski F. et al. Novel Arylsulfoanilide−Oxindole Hybrid as an Anticancer Agent That Inhibits Translation Initiation. J Med Chem 2004; 47: 4979-4982
• 19 Ma T, Fuld AD, Rigas JR. et al. A Phase I Trial and in vitro Studies Combining ABT-751 with Carboplatin in Previously Treated Non-Small Cell Lung Cancer Patients. Chemotherap 2012; 58: 321-329
• 20 Dekker M. In Protease Inhibitors in AIDS Therapy. Ed: R.C. Ogden, C.W. Flexner New York, NY Basel 2001; 5: 789
• 21 Roush WR, Gwaltney SL, Cheng J. et al. Vinyl Sulfonate Esters and Vinyl Sulfonamides:  Potent, Irreversible Inhibitors of Cysteine Proteases. Am. Chem. Soc 1998; 120: 10994-10995
• 22 Weatherburn MW. Phenol-hypochlorite reaction for determination of ammonia. Anal Chem 1967; 39: 971-974
• 23 Channar PA, Saeed A, Albericio F. et al. Sulfonamide-Linked Ciprofloxacin, Sulfadiazine and Amantadine Derivatives as a Novel Class of Inhibitors of Jack Bean Urease; Synthesis, Kinetic Mechanism and Molecular Docking. Molecules 2017; 22: 1352
• 24 Raza H, Abbas Q, Hassan M. et al. Isolation, characterization, and in silico, in vitro and in vivo antiulcer studies of isoimperatorin crystallized from Ostericum koreanum”. Pharma Biol 2017; 55: 218-226
• 25 Reddy CVK, Sreeramulu D, Raghunath M. Antioxidant activity of fresh and dry fruits commonly consumed in India. Food Res Int 2010; 43: 285-288
• 26 Ashraf Z, Rafiq M, Seo SY. et al. Synthesis, kinetic mechanism and docking studies of vanillin derivatives as inhibitors of mushroom tyrosinase. Bioorg Med Chem 2015; 23: 5870-5880
• 27 Saeed A, Mahesar PA, Channar PA. et al. "Hybrid pharmacophoric approach in the design and synthesis of coumarin linked pyrazolinyl as urease inhibitors, kinetic mechanism and molecular docking. Chem Biodivers 2017; 14
• 28 Pettersen EF, Goddard TD, Huang CC. et al. UCSF Chimera–a visualization system for exploratory research and analysis. J Comput Chem 2004; 25: 1605-1612
• 29 Chen VB, Arendall 3rd WB, Headd JJ. et al. MolProbity: All-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr 2010; 66: 12-21
• 30 Willard L, Ranjan A, Zhang H. et al. VADAR: A web server for quantitative evaluation of protein structure quality. Nucleic Acids Res 2003; 31: 3316-3319
• 31 Friesner RA, Murphy RB, Repasky MP. et al. Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein-Ligand Complexes. J Med Chem 2006; 49: 6177-6196
• 32 Farid R, Day T, Friesner RA. et al. New insights about HERG blockade obtained from protein modeling, potential energy mapping, and docking studies. Bioorg Med Chem 2006; 14: 3160-3173
• 33 Abbasi MA, Tariq S. Aziz-ur-Rehman et al Synthesis of Some New N-substituted-2,3-dihydro-[1,4]-benzodioxin-6-yl)-4-acetamidobenzenesulfonamides as valuable Antibacterial Agents. Russ J Bioorg Chem 2016; 42: 198-209
• 34 Kadam RU, Roy N. Recent trends in drug-likeness pre-diction: A comprehensive review of in silico methods. Indian J Pharm Sci 2007; 69: 609-615
• 35 Tian S, Wang J, Li Y. et al. The application of in silico drug-likeness predictions in pharmaceutical research. Adv Drug Deliv Rev 2015; 86: 2-10
• 36 Abdul Fattah T, Saeed A, Channar PA. et al. Synthesis, enzyme inhibitory kinetics, and computational studies of novel 1-(2-(4-isobutylphenyl) propanoyl)-3-arylthioureas as Jack bean urease inhibitors. Chem Biol Drug Des 2018; 91: 434-447
• 37 Channar PA, Saeed A, Albericio F. et al. Sulfonamide-Linked Ciprofloxacin, Sulfadiazine and Amantadine Derivatives as a Novel Class of Inhibitors of Jack Bean Urease; Synthesis, Kinetic Mechanism and Molecular Docking. Molecules 2017; 16 22: E1352 10.3390/molecules22081352